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Abstract
 
GATA transcription factors are major regulators of hematopoietic and immune system. Among
GATA factors, GATA-1, GATA-2, and GATA-3 play crucial roles in the development of
erythroid cells, hematopoietic stem, and progenitor cells, and T helper type 2 (Th2) cells, re-
spectively. A high level of GATA-1 and GATA-2 expression has been observed in eosinophils,
but their roles in eosinophil development remain uncertain both in vitro and in vivo. Here we
show that enforced expression of 
 
GATA-1
 
 in human primary myeloid progenitor cells com-
pletely switches myeloid cell fate into eosinophils. Expression of 
 
GATA-1
 
 exclusively pro-
motes development and terminal maturation of eosinophils. Functional domain analyses re-
vealed that the COOH-terminal finger is essential for this capacity while the other domains are
dispensable. Importantly, GATA-1–deficient mice failed to develop eosinophil progenitors in
the fetal liver. On the other hand, GATA-2 also showed instructive capacity comparable to
GATA-1 in vitro and efficiently compensated for GATA-1 deficiency in terms of eosinophil
development in vivo, indicating that proper accumulation of GATA factors is critical for eosin-
ophil development. Taken together, our findings establish essential and instructive roles of
GATA factors in eosinophil development. GATA-1 and GATA-2 could be novel molecular
targets for therapeutic approaches to allergic inflammation.
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Introduction
 
Eosinophils play important roles in host immune defense
against helminthic parasites and in the pathophysiology of
allergic diseases. Eosinophils develop from progenitor cells
in the bone marrow under the control of cytokines includ-
ing IL-3, GM-CSF, and IL-5 (1). In allergic diseases, eo-
sinophils are specifically recruited to the site of allergic in-
flammation through specific upregulation of adhesion and
chemoattractive molecules as well as increased production
of eosinophils in the bone marrow (2).
Transcriptional regulation is a key step in the commit-
ment and differentiation of hematopoietic cells (3, 4).
Through detailed analyses of eosinophil-specific promoters,
GATA-1, CCAAT/enhancer binding protein (C/EBP)
 
*
 
factors, and RFX have been implicated in the eosinophil-
specific gene expression (5–7). Among them, C/EBP and
GATA-1 have been characterized in the chicken trans-
formed hematopoietic system, in which C/EBP factors
drive eosinophil differentiation of the chicken transformed
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RT, reverse transcription. 
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hematopoietic progenitor cells (8) and an intermediate
level of GATA-1 reprograms chicken myelomonocytic cell
lines into eosinophils (9). On the other hand, friend of
GATA-1 (FOG-1), a cofactor for GATA-1, inhibits eo-
sinophil differentiation (10). These findings indicate that
GATA-1, C/EBP, and FOG-1 act within a regulatory loop
during the chicken eosinophil development. Consistent
with these findings, C/EBP
 
 
 
-deficient mice shows a selec-
tive block in the development of eosinophils as well as
neutrophils (11). Furthermore, we have recently shown
that enforced expression of C/EBP
 
 
 
 in human CD34
 
 
 
myeloid progenitor cells facilitates both eosinophil and
neutrophil development (12). In contrast, the role of
GATA-1 in eosinophil development has not yet been char-
acterized in primary hematopoietic cells or in genetically
altered mice.
GATA factors comprise a family of transcription factors
that have highly conserved zinc finger DNA binding do-
mains. Among six members, GATA-1, GATA-2, and
GATA-3 play major roles in hematopoietic and immune
system, especially in the development of erythroid cells,
hematopoietic stem and progenitor cells, and Th2 cells, re-
spectively (13–17). In addition, expression of GATA-1
and GATA-2 are specifically observed in eosinophils and
mast cells during myeloid differentiation (18). We have
previously demonstrated that GATA-1 and GATA-2 are
differentially expressed during mast cell development and
play important roles in establishing diverse mast cell popu-
lation (19). In this study, we analyzed the roles of
GATA-1 and GATA-2 in eosinophil development both in
vitro and in vivo and disclosed their novel functions in or-
ganizing immune system.
 
Materials and Methods
 
Mice.
 
Generation of mice with an erythroid promoter-spe-
cific “knock-down” allele of the 
 
GATA-1
 
 gene (
 
GATA-1.05
 
mice) has been described previously (14). 
 
IE3.9int
 
 is the mouse
GATA-1 gene regulatory region that contains 3.9 kb of 5
 
 
 
 se-
quence to the IE exon, the IE exon itself, the first intron, and a
part of the second exon of the 
 
GATA-1
 
 gene. 
 
IE3.9int
 
 is capable
of conferring the complete 
 
GATA-1
 
 expression profile to a re-
porter transgene in hematopoietic cells (20). Generation of
 
IE3.9int
 
-directed green fluorescent protein (GFP) transgenic
mice and rescue experiments of 
 
GATA-1.05
 
 mice by 
 
IE3.9int
 
-
directed GATA factor transgenes have been described (20, 21).
 
Production of Retrovirus.
 
A series of mouse GATA-1 mutant
cDNAs were described previously (21). Dominant negative-type
GATA genes were generated by replacing NH
 
2
 
-terminal portion
of GATA-1 (amino acids 1–167) and GATA-2 (amino acids
1–259) with the engrailed repression domain (amino acids 2–298;
reference 22). All cDNAs were FLAG-tagged at the NH
 
2
 
 termi-
nus, then subcloned into the retrovirus vector GCsam, which has
an LTR derived from MSCV and intact splice donor and splice
acceptor sequences for generation of subgenomic mRNA (23).
To produce the recombinant retrovirus, the retrovirus vector was
transfected into 293gp cells (293 cells containing the 
 
gag
 
 and 
 
pol
 
genes but lacking an envelope gene) along with 10A1 
 
env
 
 expres-
sion plasmid (pCL-10A1) by CaPO
 
4
 
 coprecipitation and the su-
pernatant from the transfected cells was collected to infect cells.
 
Preparation of Human Primary and Cultured Cells.
 
Human um-
bilical cord blood samples were obtained, with informed con-
sent, from placentas of full-term normal newborn infants. After
isolation of mononuclear cells by density gradient centrifugation,
CD34
 
 
 
 hematopoietic progenitors were obtained using mag-
netic bead separation (Miltenyi Biotech). In all experiments,
 
 
 
95% of purified cells were positive for CD34 as judged by spe-
cific antibody (23). For reverse transcription (RT)-PCR analysis,
cord blood CD34
 
 
 
 cells and glycophorin A
 
 
 
 erythroblasts were
purified by cell sorting on a FACS Vantage™ (Becton Dickin-
son). To obtain eosinophils, cord blood CD34
 
 
 
 cells were incu-
bated in the presence of 50 ng/ml stem cell factor (SCF), IL-3,
and GM-CSF for 5 d, then further incubated in the presence of
IL-5 (50 ng/ml) only for 10 d. To exclude macrophages, cul-
tured cells were stained with PE-conjugated CD14 (BD Phar-
Mingen), and then CD14-negative cells were collected by cell
sorting. May-Grüenwald Giemsa staining revealed almost all cells
collected are eosinophils.
 
Transduction of CD34
 
 
 
 Cells.
 
CD34
 
 
 
 cells were prestimu-
lated in IMDM (Sigma-Aldrich) supplemented with 10% FBS, 50
ng/ml SCF, thrombopoietin (TPO; kindly provided by KIRIN,
Tokyo, Japan), IL-6, and Flt-3 ligand (PeproTech) for 20 h. After
replating onto recombinant fibronectin fragment-coated culture
dishes (Takara Shuzo) containing virus supernatant and 5 
 
 
 
g/ml
protamine sulfate (Sigma-Aldrich), cells were centrifuged at 1,000 
 
g
 
for 30 min. Transduction was repeated with fresh virus superna-
tant every 12 h three times. At 60 h after the first transduction,
cells were stained with PE-conjugated anti-CD34 (BD PharMin-
gen). Cells positive for both CD34 and enhanced GFP (EGFP)
were selected by cell sorting and subjected to subsequent analyses.
At this time point, around 85% of the cells were still positive for
CD34 (23)
 
In Vitro Colony Assay and Liquid Culture.
 
CD34
 
 
 
 cells trans-
duced with indicated retroviruses were plated in methylcellulose
medium (StemCell Technologies, Inc.) or cultured in IMDM
with 10% FBS. Cytokines were supplemented to culture at the
concentrations of 50 ng/ml human SCF, GM-CSF, IL-3, and IL-5
(PeproTech), and 5 U/ml human erythropoietin (kindly provided
by Chugai Pharmaceutical Inc., Tokyo, Japan). The culture dishes
were incubated at 37
 
 
 
C in a 5% CO
 
2
 
 atmosphere. Colony num-
bers were counted at day 14. To check the development of IL-5–
responsive eosinophils, cells were cultured in the presence of SCF
and GM-CSF for the first 5 d. Then, cells were further incubated
in the presence of IL-5 alone. Alternatively, preculture media
were supplemented with IL-3 in addition to SCF and GM-CSF
to facilitate development of eosinophil progenitors.
 
Analysis of Eosinophil Development in Mice.
 
The fetal liver cell
suspensions were prepared by dissecting E11.5 fetal livers by pi-
petting. The bone marrow cell suspensions were prepared from
adult mice and were overlaid with sodium metrizoate solution
(1.086 g/ml; Nycomed), then centrifuged at 400 
 
g
 
 for 20 min.
The low-density cells were harvested and stained with anti-lin-
eage marker antibodies (Mac-1, Gr-1, B220, CD4, CD8, and
TER119; BD PharMingen), then lineage marker-negative (Lin
 
–
 
)
cells were collected by cell sorting. The fetal liver and Lin
 
–
 
 bone
marrow cells were plated in methylcellulose medium (StemCell
Technologies, Inc.) in the presence of mouse IL-5 (50 ng/ml;
Genzyme) or in the presence of mouse SCF, IL-3 (10 ng/ml),
and human erythropoietin (5 U/ml). Colony numbers were
counted at day 10.
 
Flow Cytometric Analysis.
 
Expression of the cell surface and
cytoplasmic antigens was analyzed on a FACS Vantage™. To de-
tect cell surface antigens, cells were stained with allophycocyanin 
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(APC)-conjugated anti–human CD11b and PE-conjugated CD14
(BD PharMingen). To detect cytoplasmic major basic protein
(MBP), cells were fixed in 4% paraformaldehyde and permeabi-
lized in 0.3% saponin, then stained with anti–human MBP
(Nichirei) followed by PE-conjugated anti–mouse immunoglob-
ulins (BD PharMingen). Cells that marked with propidium io-
dide were gated out as dead cells.
 
Cytochemical Analysis.
 
Cells were cytocentrifuged onto glass
slides and were stained by May-Grüenwald Giemsa staining. To
detect eosinophil-specific granules, cytospun cells were fixed in
methyl alcohol, then stained with 0.2% Fast green (Sigma-
Aldrich) in 70% ethyl alcohol. To detect eosinophil peroxidase
(EPO) expression, cytospun cells were fixed in 4% paraformalde-
hyde and 60% acetone, then stained with anti–human EPO (BD
PharMingen) followed by EnVision labeled polymer/alkaline
phosphatase (Dako).
 
RT-PCR.
 
Total RNA was isolated from sorted cells using
ISOGEN-LS solution (Nippon Gene) and reverse-transcribed us-
ing ThermoScript RT-PCR system (GIBCO BRL) and oligo-
dT primer. The amount of cDNA was normalized by the quanti-
tative PCR using TaqMan rodent GAPDH control reagent
(PerkinElmer/Applied Biosystem). Semi-quantitative RT-PCR
reactions were then performed for 35 cycles using normalized
cDNAs and recombinant Taq DNA polymerase (Takara). Cy-
cling parameters were denaturation at 94
 
 
 
C for 20 s, annealing at
58
 
 
 
C for 20 s, and extension at 72
 
 
 
C for 30 s. PCR products
were separated on agarose gels and visualized by ethidium bro-
mide staining. The primer sequences were: GATA-1 sense
primer 5
 
 
 
-TCA ATT CAG CAG CCT ATT CC-3
 
 
 
; antisense
primer 5
 
 
 
-TTC GAG TCT GAA TAC CAT CC-3
 
 
 
, GATA-2
sense primer 5
 
 
 
-TGT TGT GCA AAT TGT CAG ACG-3
 
 
 
; an-
tisense primer 5
 
 
 
-CAT AGG TGC CAT GTG TCC AGC-3
 
 
 
,
GATA-3 sense primer 5
 
 
 
-AAG TGC ATG ACT CAC TGG
AGG-3
 
 
 
; antisense primer 5
 
 
 
-TAG GCT TCA TGA TAC TGC
TCC-3
 
 
 
.
 
Results
 
Expression of GATA Family Genes in Eosinophils.
 
High
levels of mRNA expression of GATA genes have been re-
ported in human primary eosinophils (18). In this study,
RT-PCR analysis also demonstrated that expression of
 
GATA-1
 
 and 
 
GATA-2
 
 in human eosinophils is compara-
ble to that in hematopoietic progenitor cells and/or eryth-
roblasts. In contrast, expression of GATA-3 was not sig-
nificant in eosinophils (Fig. 1 A). Next, we analyzed
expression of 
 
GATA-1
 
 in mouse eosinophils. We previ-
ously generated transgenic mice bearing 
 
IE3.9int
 
-directed
GFP (20). 
 
IE3.9int
 
 is the GATA-1 gene regulatory region
that contains 3.9 kb of 5
 
 
 
 sequence to the IE exon, the IE
exon itself, the first intron, and a part of the second exon
of the 
 
GATA-1
 
 gene. 
 
IE3.9int
 
 is capable of conferring the
complete 
 
GATA-1
 
 expression profile to a reporter trans-
gene in hematopoietic cells (20). IL-5 is a late-acting cy-
tokine that specifically supports eosinophil proliferation.
In the presence of IL-5 alone, bone marrow cells from
transgenic mice predominantly gave rise to GFP-positive
colonies (Fig. 1 B). All the GFP-positive colonies con-
sisted of mature eosinophils, which were positive for fast
green staining that detects eosinophil granules (data not
shown). On the other hand, the colonies of neutrophils
 
and/or macrophages formed in the presence of IL-3 did
not express GFP at all (data not shown). These findings in-
dicate that the transcription of 
 
GATA-1
 
 gene is active in
mouse eosinophils.
 
Role of GATA Factors in Eosinophil Development In Vitro.
 
Roles of GATA factors in eosinophil development have
not yet been characterized in primary hematopoietic system.
By using retrovirus, we expressed 
 
GATA-1
 
, 
 
GATA-2
 
, and
their dominant negative-type genes in human CD34
 
 
 
 he-
matopoietic progenitor cells. The dominant negative GATA-1
and GATA-2 contain engrailed repression domain instead
of their own NH
 
2
 
-terminal activation domain (Fig. 2 A),
which strongly repress GATA-dependent transcriptional
activation. The retroviral vector drives expression of both
GATA-related genes and EGFP from a single bicistronic
message. After transduction, cells positive for both CD34
and EGFP were selected by cell sorting and subjected to in
vitro assay.
To evaluate the effects of GATA-1 and GATA-2 on
eosinophil commitment, we first assessed the frequency of
eosinophil colony formation. In the presence of SCF and
GM-CSF, CD34
 
 
 
 cells transduced with either 
 
GATA-1
 
 or
 
GATA-2
 
 gave rise to comparable number of colonies to
the control. Surprisingly, in contrast with the control that
predominantly gave rise to granulocyte/macrophage colo-
nies, CD34
 
 
 
 cells expressing either 
 
GATA-1
 
 or 
 
GATA-2
 
exclusively gave rise to eosinophil colonies (Fig. 2 B). Eo-
sinophil colonies consisted of mature eosinophils, which
were positive for fast green staining that detects eosinophil
Figure 1. Expression of GATA family genes in eosinophils. (A) Ex-
pression of GATA family genes in human eosinophils. RT-PCR was per-
formed on normalized cDNA templates from cord blood CD34  cells,
glycophorin A  erythroblasts, and eosinophils obtained by in vitro culture
(details in Materials and Methods). Lane H2O represents the negative
control without template. (B) Expression of GATA-1 in mouse eosino-
phils. Eosinophil colonies were generated from bone marrow cells of
transgenic mice bearing IE3.9int-directed GFP in the presence of IL-5
alone. Bright field microgram (left) and fluorescence microgram (right). 
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granules (Fig. 2 C). There was no significant difference in
erythroid colony formation between the control and
GATA-expressing cells (Fig. 2 B; BFU-E).
In liquid culture supplemented with SCF and GM-CSF
that allows myeloid cell development, cells transduced with
either 
 
GATA-1
 
 or 
 
GATA-2
 
 showed slightly decreased cell
growth compared with the control, and cells transduced
with dominant negative GATA genes showed even lower
cell growth rate (Fig. 3 A). To check the development of
IL-5–responsive eosinophil progenitors, the transduced cells
were cultured in the presence of SCF and GM-CSF for the
first 5 d, and then cytokines were replaced with IL-5, the
cytokine that specifically supports eosinophil proliferation.
Only cells transduced with 
 
GATA-1 or GATA-2 prolifer-
ated in an IL-5-dependent manner (Fig. 3 A). Next, we
supplemented culture medium with IL-3 in addition to SCF
and GM-CSF. Under this cytokine condition, eosinophil
development is further promoted and even the control cells
showed IL-5–dependent cell growth. However, the cells
transduced with dominant negative GATA genes did not
respond to IL-5 at all (Fig. 3 A), indicating an crucial role of
GATA factors for the development of eosinophil progeni-
tors in vitro. Flow cytometric analysis revealed that cells ex-
pressing GATA genes failed to develop CD14  macro-
phages, but gave rise to MBP-positive eosinophils (Fig. 3 B).
Cytological analyses again demonstrated the eosinophilic
features of transduced cells, which were positive for both
EPO and fast green staining (Fig. 3 C). These data clearly
show that GATA-1 and GATA-2 have a strong instructive
ability to render myeloid progenitor cells to commit into
eosinophils and to support their terminal differentiation.
Figure 2. GATA-1 and GATA-2 promote human eosinophil develop-
ment. (A) Schematic representation of the retroviral vector, GCsam-IRES-
EGFP, harboring wild-type or dominant negative GATA genes linked by
an internal ribosome entry site (IRES) to a cDNA encoding EGFP.   ,
packaging signal; SD, splice donor; SA, splice acceptor; F, Flag-tag; AD,
activation domain; NF, NH2-terminal zinc finger; CF, COOH-terminal
zinc finger; En, engrailed repression domain. (B) Colony formation of
CD34  cells transduced with wild-type GATA genes. Human CD34 
hematopoietic progenitor cells transduced with empty vector (control),
GATA-1 or GATA-2 were cultured in methylcellulose medium. CFU-
GM/M, CFU-granulocyte/macrophage and macrophage, BFU-E, ery-
throid burst-forming unit. Results are shown as mean   SD per 1,000 cells
of three representative experiments. (C) The morphology of an eosinophil
colony generated from GATA-1–transduced CD34  progenitor cells.
Morphology under a phase-contrast microscope (left). The eosinophil col-
ony was lifted and cytocentrifuged onto a glass slide, then stained by May-
Grüenwald Giemsa staining (middle) and Fast green staining (right).
Figure 3. Effect of GATA
genes on eosinophil develop-
ment. (A) Cell growth and differ-
entiation of CD34  progenitor
cells transduced with either
wild-type GATA or dominant
negative GATA. Cytokine-depen-
dent growth of transduced cells
was evaluated by liquid culture.
To evaluate IL-5–dependent cell
growth, cells were cultured in
the presence of SCF and GM-
CSF for the first 5 d. Then, cy-
tokines were replaced to IL-5
alone (middle). Alternatively,
preculture media were supple-
mented with IL-3 in addition to
SCF and GM-CSF to facilitate
development of eosinophil pro-
genitors (right). Results are
shown as mean   SD of three
representative experiments. (B)
Flow cytometric profiles of
transduced cells cultured for
10 d in the presence of SCF and
GM-CSF. The percentages of
CD11b CD14  macrophages
and MBP  eosinophils are indi-
cated. (C) Eosinophilic features
of GATA-expressing cells. CD34  progenitor cells transduced with wild-type GATA genes were cultured for 10 d in the presence of SCF and GM-CSF,
then analyzed by May-Grüenwald Giemsa staining (MGG), Fast Green staining (FG), and immunostaining for intracytoplasmic EPO. 1383 Hirasawa et al.
GATA-1 Functional Domains Responsible for Eosinophil
Development. To clarify the requirement for GATA-1
functional domains during eosinophil development, we in-
troduced a series of GATA-1 mutants into CD34  progen-
itor cells. The GATA-1 mutants used are an NH2-terminal
deletion ( NT), an NH2-terminal zinc finger deletion
( NF), a COOH-terminal zinc finger deletion ( CF), and
a mutant that lacks both the NH2 terminus and the NH2-
terminal zinc finger ( NTNF; reference 21). We further
generated an additional mutant with a single amino acid
substitution of valine 205 into glycine (V205G) that abol-
ishes interaction with FOG-1 (V205G; Fig. 4 A). In the
colony assay supplemented with SCF and GM-CSF,
CD34  progenitor cells transduced with wild-type GATA-1,
 NF, or V205G gave rise to comparable number of eo-
sinophil colonies (Fig. 4 B). Notably, CD34  cells trans-
duced with  NT gave rise to a higher number of eosino-
phil colonies. CD34  cells transduced with  NTNF
formed slightly decreased number of eosinophil colonies.
Cells with  CF were even more inefficient in forming
eosinophil colonies and formed a significant number of
granulocyte/macrophage colonies. Importantly, the eo-
sinophil colonies generated from cells transduced with
 NTNF or  CF were much smaller in size than the others
(data not shown).
In liquid culture supplemented with SCF and GM-CSF,
cells transduced with  NT and  NTNF showed compa-
rable cell growth with the control while the others
showed retarded cell growth (Fig. 4 C, left panel). EPO
staining revealed that  NT,  NF, and V205G efficiently
Figure 4. GATA-1 functional domains respon-
sible for eosinophil development.  (A) Schematic
representation of GATA-1 mutants. (B and C)
Growth and differentiation of CD34  cells trans-
duced with GATA mutants. (B) CD34  cells
transduced with empty vector (control), wild-type
GATA-1, or GATA-1 mutants were cultured for
14 d in methylcellulose medium supplemented
with SCF and GM-CSF. (C) Cytokine-dependent
cell growth was also evaluated by liquid culture as
in Fig. 3 A. Results are shown as mean   SD of
three representative experiments. (D) Effects of
GATA-1 mutants on eosinophil development.
Transduced CD34  progenitor cells were cultured
for 10 d in the presence of SCF and GM-CSF,
then analyzed by immunostaining for intracyto-
plasmic EPO. The percentages of EPO  eosino-
phils are indicated as mean   SD of three repre-
sentative experiments.1384 GATA Factors in Eosinophil Development
drive eosinophil development while  NTNF is less effi-
cient and  CF barely induces eosinophil development
(Fig. 4 D). As expected from these data, IL-5–responsive
cell growth was promoted with cells transduced with
wild-type GATA-1,  NT,   NF, or V205G, and was
most evident with  NT-transduced cells. In contrast, cells
with  NTNF poorly responded to IL-5 and  CF did not
respond at all (Fig. 4 C, right panel). All these data indicate
that both NT and NF domains are dispensable in promot-
ing eosinophil development, and the CF domain is abso-
lutely required in this process.
Essential Role of GATA Factors in Eosinophil Development
In Vivo. Analyses of definitive hematopoiesis in the
GATA-1–deficient fetal liver thus far have demonstrated
defects in differentiation specific to erythroid and mega-
karyocytic lineages (13–15). Eosinophil development oc-
curs in the fetal liver from the definitive hematopoietic
stem cells. To determine the role of GATA-1 in eosinophil
development in vivo, we analyzed the development of
eosinophil progenitor cells in the GATA-1–deficient fetal
livers (Table I). We previously generated mice with an
erythroid promoter-specific mutant allele of the GATA-1
gene (GATA-1.05 mice), in which GATA-1 was ex-
pressed at  5% of the wild-type level (14). Because
GATA-1 is located on the X chromosome, all male em-
bryos hemizygous for the mutation show GATA-1–defi-
cient phenotypes. As previously observed, the mutant fetal
livers showed defective erythropoiesis and contained much
less nucleated cells than the wild-type livers. Nonetheless,
they contained similar numbers of colony forming units to
the wild-type livers. Notably, IL-5–responsive eosinophil
colonies were formed from wild-type fetal liver cells but
not from mutant fetal liver cells, indicating that eosinophil
progenitor cells do not develop in the absence of GATA-1.
We next analyzed if transgenic expression of GATA factor
genes could rescue deficient eosinophil development in
GATA-1.05 mice. We previously succeeded to rescue the
embryonic lethal phenotype of GATA-1.05 mice by
GATA factor transgenes under the control of the GATA-1
IE3.9int gene (20). Although rescued mice by GATA-2
but not by GATA-1 transgene develop anemia after birth,
they survive and were subjected to analysis for eosinophil
development. As expected from in vitro data in Figs. 2 and
3, GATA-2 as well as GATA-1 transgenes efficiently com-
pensated for GATA-1 deficiency in terms of eosinophil de-
velopment in vivo (Table II).
Table I. Eosinophil Progenitors in the Fetal Liver
No. of CFU
per liver per 105 cells
Genotype Embryo no. Total cell no. ( 105) Eosino GM/Mix Eosino GM/Mix
male (y/ ) 1 0.30 0.00 950 0.00 3,167.0
2 0.20 0.00 1,560 0.00 7,800.0
3 0.15 0.00 1,230 0.00 8,200.0
Avg. (n   3) 0.22 0.00 1,247 0.00 6,389.0
female ( / )4  ( n   1) 2.00 26.64 4,130 13.32 2,065.0
male (y/ ) 5 1.60 25.53 460 15.96 287.5
6 2.40 45.51 1,290 18.96 537.5
7 3.60 16.65 2,160 4.59 595.0
8 3.00 42.18 1,580 14.06 526.7
Avg. (n   4) 2.40 32.47 1,373 13.39 486.7
female ( / ) 9 2.70 21.09 1,000 7.81 370.4
10 3.50 62.16 2,440 17.76 697.1
11 4.00 34.41 2,060 8.60 515.0
12 4.78 57.72 2,320 12.15 488.4
13 4.25 56.61 2,440 13.32 574.1
Avg. (n   5) 3.84 46.40 2,052 11.93 529.0
E11.5 fetal liver cells were plated in methylcellulose medium supplemented with IL-5 alone (for CFU-Eo) or SCF, IL-3, and erythropoietin (for
CFU-GM/Mix). Colony numbers were counted at day 10. CFU/Mix, mixed-CFU. Numbers of nucleated cells recovered from the fetal liver, CFU
per liver and CFU per 105 nucleated cells are presented.1385 Hirasawa et al.
Discussion
Eosinophils develop from myeloid progenitor cells along
with neutrophils and macrophages. In this study, we dem-
onstrated that GATA-1 strongly promotes eosinophil com-
mitment of primary myeloid progenitor cells and supports
their terminal differentiation. This effect was much more
drastic than that of GATA-1 to reprogram chicken trans-
formed myeloblasts into eosinophils. In addition, we clearly
showed an essential role of GATA-1 in eosinophil devel-
opment in vivo. These data establish GATA-1 as an essen-
tial regulator for eosinophil development.
Thus far, C/EBP  is known to be essential for eosino-
phil development (11). However, C/EBP  is also crucial
for neutrophil development (11). Enforced expression of
C/EBP  in human CD34  myeloid progenitor cells facili-
tates both eosinophil and neutrophil development (12). In
contrast, GATA-1 exclusively promoted eosinophil devel-
opment in this study. With respect to induction of eosino-
phil development, GATA-1 is more specific and efficient
than C/EBP . These data indicate that the expression of
GATA-1 in combination with C/EBP  could be the criti-
cal determinant for eosinophil lineage commitment. On
the other hand, GATA-2 showed instructive capacity com-
parable to GATA-1 in vitro and efficiently compensated
for GATA-1 deficiency in terms of eosinophil develop-
ment in vivo, indicating that proper accumulation of
GATA factors is essential for eosinophil development.
However, endogenous GATA-2 did not compensate for
the loss of GATA-1 function in vivo as has been observed
in erythropoiesis (13, 14). These data may also indicate
functional distinctions between GATA-1 and GATA-2.
The role of GATA-2 in eosinophil development in vivo
remains to be determined.
Structural analysis of GATA-1 in eosinophil development
revealed that the NT and NF domains are dispensable in
promoting eosinophil development. In addition, interaction
with FOG-1 was not vital. These profiles of domain re-
quirement are in good agreement with those of GATA-1 in
the chicken eosinophil development that does not require
the NF domain (10), but contrast with those of GATA-3 in
Th2 development, in which each of the functional domains
is required (24). Although we cannot directly compare these
data with those of in vivo rescue experiments in GATA-
1.05 mutants, we previously showed that either NT or NF
domain is dispensable during primitive but not definitive
erythropoiesis (21). As CF encompasses the DNA-binding
domain, these data indicate that the site-specific DNA bind-
ing is sufficient for the initiation of eosinophil development
from primary myeloid progenitor cells that retain multipo-
tency in differentiation. Interestingly,  NT was most effi-
cient in promoting eosinophil development, indicating that
the NT domain mediates some negative regulations for
eosinophil commitment or proliferation. The NT domain
could play distinct functions in eosinophils from those in
other cell lineages. Although  CF do not bind to DNA,
it slightly promoted eosinophil development. This effect
could be mediated by indirect mechanism, for example, by
sequestrating GATA-interacting factors such as FOG-1,
which could negatively regulate GATA-1 in eosinophils
(10), thereby enhancing endogenous GATA-1 function.
To inhibit Th2 lymphocyte–mediated allergic inflamma-
tion, many approaches have been taken that target GATA-3,
such as local delivery of GATA-3 antisense oligonucle-
otides (25). Our data clearly implicated GATA-1 and
GATA-2 in the regulation of eosinophil development and
function. In addition, we have previously demonstrated
that GATA-1 and GATA-2 play differential but important
roles in mast cell differentiation and function (19). Because
eosinophils and mast cells are largely responsible for devel-
opment and progression of allergic inflammation, and
GATA-1 and GATA-2 are predominantly expressed in
eosinophils and mast cells in the site of allergic inflamma-
tion, GATA-1 and GATA-2 could be new therapeutic tar-
gets for the local treatment of allergy.
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Table II. Transgenic Rescue of GATA-1.05 Mutant Mice
CFU per 105 Lin  cells
Genotype Mouse no. Eosino GM/Mix
Male (y/ ) 1 21.8 2,740
2 28.1 3,880
3 22.0 3,150
Avg. (n   3) 23.9 3,257
Male (y/ )::
GATA-1 transgene
4 (n   1) 13.0 2,720
Male (y/ )::
GATA-2 transgene
5 13.8 4,370
6 25.6 4,130
Avg. (n   2) 19.7 4,250
Lineage marker–negative (Lin ) bone marrow cells that did not react
with anti-lineage marker antibodies (Mac-1, Gr-1, B220, CD4, CD8,
and TER119) were collected by cell sorting and plated in
methylcellulose medium supplemented with IL-5 alone (for CFU-Eo)
or SCF, IL-3, and erythropoietin (for CFU-GM/Mix). Colony
numbers were counted at day 10. Numbers of CFU per 105 Lin  cells
are presented.1386 GATA Factors in Eosinophil Development
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